Financial Consulate’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Financial Consulate's NVS Position: Q1 2026 in Review
Financial Consulate increased its Novartis (NVS) stake by 213% in Q1 2026, buying an estimated $50.3K and bringing the position to 482 shares worth $73.6K. The position accounts for 0.01% of the portfolio, ranked #257.
Financial Consulate first reported a position in NVS in Q3 2025 and has held it in 3 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Financial Consulate held 482 shares of Novartis worth $73.6K as of Q1 2026.
- Financial Consulate bought 328 Novartis shares in Q1 2026, an estimated $50.3K.
- Novartis made up 0.01% of Financial Consulate's portfolio in Q1 2026, its #257 holding.
- Financial Consulate first reported a position in Novartis in Q3 2025 and has held it in 3 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.